Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
765
-
Total 13F shares, excl. options
-
236M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$33.9B
-
Value change
-
+$285M
-
Put/Call ratio
-
0.97
-
Number of buys
-
308
-
Number of sells
-
-359
-
Price
-
$143.77
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2016
856 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2016.
Elevance Health, Inc. - Common Stock (ELV) has 765 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 236M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (16.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.8M shares), FMR LLC (11.4M shares), STATE STREET CORP (11M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (8.05M shares), BlackRock Institutional Trust Company, N.A. (7.4M shares), NORDEA INVESTMENT MANAGEMENT AB (6.2M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (5.87M shares), BAILLIE GIFFORD & CO (5.14M shares), and BlackRock Advisors LLC (4.77M shares).
This table shows the top 765 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.